Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function with aging and tauopathy
D. Wahl, S. J. Risen, S. C. Osburn, T. Emge, S. Sharma, V. S. Gilberto, A. Chatterjee, P. Nagpal, J. A. Moreno, T. J. LaRocca
This study shows that Nanoligomers targeting NF-κB and NLRP3 reduce neuroinflammation and improve cognitive function in aged and tauopathy mouse models.
bioRxiv · Feb 3, 2024Physiology